Last Updated: May 14, 2026

List of Excipients in API cobimetinib

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing cobimetinib

Subscribe to access the full database, or Start Trial
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Genentech Inc	COTELLIC	cobimetinib	50242-717	CELLULOSE, MICROCRYSTALLINE	2030-05-10
Genentech Inc	COTELLIC	cobimetinib	50242-717	CROSCARMELLOSE SODIUM	2030-05-10
Genentech Inc	COTELLIC	cobimetinib	50242-717	LACTOSE MONOHYDRATE	2030-05-10
Genentech Inc	COTELLIC	cobimetinib	50242-717	MAGNESIUM STEARATE	2030-05-10
Genentech Inc	COTELLIC	cobimetinib	50242-717	POLYETHYLENE GLYCOL 3350	2030-05-10
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for cobimetinib

Excipient focus: CELLULOSE, MICROCRYSTALLINE

cobimetinib drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Genentech Inc	cobimetinib	50242-717
>Company	>Ingredient	>NDC

cobimetinib drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CROSCARMELLOSE SODIUM

cobimetinib drug variants containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Genentech Inc	cobimetinib	50242-717
>Company	>Ingredient	>NDC

cobimetinib drug variants not containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: LACTOSE MONOHYDRATE

cobimetinib drug variants containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Genentech Inc	cobimetinib	50242-717
>Company	>Ingredient	>NDC

cobimetinib drug variants not containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

cobimetinib drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Genentech Inc	cobimetinib	50242-717
>Company	>Ingredient	>NDC

cobimetinib drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYETHYLENE GLYCOL 3350

cobimetinib drug variants containing POLYETHYLENE GLYCOL 3350

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Genentech Inc	cobimetinib	50242-717
>Company	>Ingredient	>NDC

cobimetinib drug variants not containing POLYETHYLENE GLYCOL 3350

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYVINYL ALCOHOL

cobimetinib drug variants containing POLYVINYL ALCOHOL

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Genentech Inc	cobimetinib	50242-717
>Company	>Ingredient	>NDC

cobimetinib drug variants not containing POLYVINYL ALCOHOL

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TALC

cobimetinib drug variants containing TALC

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Genentech Inc	cobimetinib	50242-717
>Company	>Ingredient	>NDC

cobimetinib drug variants not containing TALC

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

cobimetinib drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Genentech Inc	cobimetinib	50242-717
>Company	>Ingredient	>NDC

cobimetinib drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.